Metraipolis › archive › dc_3fcfb0ab4d95

The Impact of Antidiabetic Therapy on Liver Injury, Steatosis, and Fibrosis in Patients with Type 2 Diabetes and Metabolic Dysfunction-Associated Steatotic… — Europe PMC PMID:41155837

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/41155837
DOI
10.3390/medicina61101850
License (as archived)
solo-consultazione
Archived
2026-11-09T07:14:04.620Z
SHA-256 of the archived text
ffb0fd3b4cc62e0254b1d7d3d174a1299e32a8154ca15e39045f0bec84f59e47
Stable URL of this page
https://metraipolis.com/documento/dc_3fcfb0ab4d95

How to cite

The Impact of Antidiabetic Therapy on Liver Injury, Steatosis, and Fibrosis in Patients with Type 2 Diabetes and Metabolic Dysfunction-Associated Steatotic… — Europe PMC PMID:41155837 — Europe PMC (en), https://europepmc.org/article/MED/41155837 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_3fcfb0ab4d95 (Metraipolis archive dc_3fcfb0ab4d95, sha256 ffb0fd3b4cc62e0254b1d7d3d174a1299e32a8154ca15e39045f0bec84f59e47)
BibTeX
@misc{dc3fcfb0ab4d95,
  title = {The Impact of Antidiabetic Therapy on Liver Injury, Steatosis, and Fibrosis in Patients with Type 2 Diabetes and Metabolic Dysfunction-Associated Steatotic… — Europe PMC PMID:41155837},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/41155837},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_3fcfb0ab4d95; sha256 ffb0fd3b4cc62e0254b1d7d3d174a1299e32a8154ca15e39045f0bec84f59e47},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/41155837. Agents can read the archived copy with the MCP tool read_document.